Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 5:01 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | RA CAPITAL MANAGEMENT L.P. | 11,609,704 18.8% | 1,923,076 (+19.85%) | View |
| 2024-02-14 4:19 pm Unchanged | 13G | FULCRUM THERAPEUTICS INC FULC | Third Rock Ventures III L.P. | 2,343,154 3.8% | 0 (Unchanged) | View |
| 2024-02-14 07:53 am Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | RTW INVESTMENTS LP | 5,469,956 8.8% | 476,677 (+9.55%) | View |
| 2024-02-13 12:08 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 5,518,881 8.9% | 1,244,078 (+29.10%) | View |
| 2024-02-09 09:03 am Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | FMR LLC | 5,684,615 9.195% | 450,890 (+8.62%) | View |
| 2024-02-07 07:44 am Sale | 13G | FULCRUM THERAPEUTICS INC FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,506,422 2.44% | -1,964,125 (-56.59%) | View |
| 2023-07-07 4:35 pm Sale | 13G | FULCRUM THERAPEUTICS INC FULC | BlackRock Inc. BLK | 1,514,425 2.5% | -1,754,566 (-53.67%) | View |
| 2023-03-06 4:40 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,470,547 5.63% | 2,350,547 (+209.87%) | View |
| 2023-02-14 4:15 pm Sale | 13G | FULCRUM THERAPEUTICS INC FULC | Point72 Asset Management L.P. | 30,702 0.1% | -2,037,172 (-98.52%) | View |
| 2023-02-14 4:07 pm Sale | 13G | FULCRUM THERAPEUTICS INC FULC | Third Rock Ventures III L.P. | 2,343,154 4.5% | -1,703,271 (-42.09%) | View |
| 2023-02-14 10:04 am Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | RTW INVESTMENTS LP | 4,993,279 9.6% | 1,126,407 (+29.13%) | View |
| 2023-02-13 10:15 am Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 4,274,803 8.2% | 1,899,232 (+79.95%) | View |
| 2023-02-09 11:39 am Sale | 13G | FULCRUM THERAPEUTICS INC FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,120,000 2.15% | -1,030,000 (-47.91%) | View |
| 2023-02-09 10:59 am Sale | 13G | FULCRUM THERAPEUTICS INC FULC | FMR LLC | 5,233,725 10.054% | -848,592 (-13.95%) | View |
| 2023-02-01 4:54 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | BlackRock Inc. BLK | 3,268,991 6.3% | 1,060,913 (+48.05%) | View |
| 2023-01-23 3:41 pm Sale | 13G | FULCRUM THERAPEUTICS INC FULC | Cowen Financial Products LLC | 1,367,759 2.615% | -729,131 (-34.77%) | View |
| 2023-01-06 4:30 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | RA CAPITAL MANAGEMENT L.P. | 9,686,628 18.6% | 2,686,628 (+38.38%) | View |
| 2022-08-26 4:38 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | RA CAPITAL MANAGEMENT L.P. | 7,000,000 13.45% | 7,000,000 (New Position) | View |
| 2022-06-22 4:14 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | Point72 Asset Management L.P. | 2,067,874 5.1% | 729,206 (+54.47%) | View |
| 2022-03-10 4:30 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,150,000 5.29% | 2,150,000 (New Position) | View |